https://www.selleckchem.com/pr....oducts/sacituzumab-g
Logistic regression identified SBS-EC and age to classify uncompensated from compensated patients with sensitivity of 83.9% and specificity of 72.4%. Then an index was created, called the Antwerp Vestibular Compensation Index, AVeCI = -50 + age × 0.486 + SBS-EC × 0.421. A patient belongs to the uncompensated group when AVeCI 0 and to the compensated group when AVeCI 0, with respective group means of -5 and 5. AVeCI stages the degree of compensation of PVD patients and can serve to evaluate rehabilitation effects.
Мне нравится
Комментарий
Перепост
